Latest Breaking News On - Astrocyte pharmaceuticals - Page 3 : comparemela.com

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesWilliam korinekElisa mannaAstrocyte pharmaceuticalsAstrocyte pharmaceuticals incDepartment of defenseUs army medical researchAmerica department of defenseDepartment of the armyClinical development operations at astrocyteTechnology enterprise consortiumDevelopment commandPharmaceuticals incMedical technology enterprise consortiumMedical researchAmerica department

The Day - Groton biotech firm working on much-needed drug to treat stroke, brain injuries

The Day - Groton biotech firm working on much-needed drug to treat stroke, brain injuries
theday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theday.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJames lechleiterWilliam korinekTed listonUs department of defenseUs centers for diseaseAstrocyte pharmaceuticalsDrug administrationShennecossett roadDisease controlTexas health science centerSan antonio

San Antonio researchers developing brain injury treatment

Scientists say the first-of-its-kind drug, developed by UTHSA researchers, could prevent long-term ailments associated with concussions and strokes.

San antonioUnited statesJim lechleiterWilliam korinekAstrocyte pharmaceuticalsUt health science center san antonioTechnology enterprise consortiumScience center san antonioMedical technology enterprise consortiumPost traumatic stress disorder

SA spinoff company advancing brain injury drug - San Antonio Business Journal

SA spinoff company advancing brain injury drug - San Antonio Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesUniversity of texasJames lechleiterW scott baileyWilliam korinekAstrocyte pharmaceuticalsUt health san antonioUniversity of texas system board regentsTechnology enterprise consortiumBrightfocus foundationSenior reporterSan antonio business journalTexas health science centerTexas system boardMedical technology enterprise consortium

Major Depressive Disorder Therapeutic Market Size Expected to Witness Growth at a CAGR of 8 91% for the Study Period 2018-2030

Major Depressive Disorder Therapeutic Market Size Expected to Witness Growth at a CAGR of 8 91% for the Study Period 2018-2030
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomShruti thakurMerz pharmaAllergan gedeon richterJohnson minerva neurosciencesMedday pharmaPrnewswire delveinsightCelon pharmaAllergan abbvie gedeon richterNovartis amgenSunovion sumitomo dainippon pharmaLuye pharmaVraylar allergan gedeon richterMinerva biosciencesNovo nordisk